Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
October 31, 2003
Primary Completion Date
September 30, 2004
Conditions
Colorectal Cancer
Interventions
DRUG
epothilone D
Trial Locations (1)
10021
Memorial Sloan-Kettering Cancer Center, New York
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Memorial Sloan Kettering Cancer Center
OTHER
NCT00077259 - Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer | Biotech Hunter | Biotech Hunter